March 6, 2020 / 2:18 PM / a month ago

BRIEF-Novadoz Pharmaceuticals Increases Presence In The Generic Oncology Market With An FDA Approval Of Thiotepa 15Mg & 100Mg Vials For Injection

March 6 (Reuters) - Novadoz Pharmaceuticals:

* NOVADOZ PHARMACEUTICALS INCREASES PRESENCE IN THE GENERIC ONCOLOGY MARKET WITH AN FDA APPROVAL OF THIOTEPA 15MG &100MG VIALS FOR INJECTION Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below